1-amino-4-methylpiperazine for COVID-19

1-amino-4-methylpiperazine has been reported as potentially beneficial for COVID-19 in the following study.
COVID-19 involves the interplay of 350+ viral and host proteins and factors providing many therapeutic targets. Scientists have proposed 10,000+ potential treatments. c19early.org analyzes 210+ treatments. We have not reviewed 1-amino-4-methylpiperazine in detail.